XRCC3 and breast cancer: In the analysis of XRCC3 Thr241Met polymorphism, women with homozygote expression (Met/Met genotype) of 241Met allele had three times increased risk of breast cancer (OR = 2.77, 95% CI = 1.26–6.11; P = 0.009).